561 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
151 | 21143106 | Long-acting insulin analogs: a review of "real-world" effectiveness in patients with type 2 diabetes. | 2011 Jan | 2 |
152 | 21338921 | Direct activation of Epac by sulfonylurea is isoform selective. | 2011 Feb 25 | 2 |
153 | 21410858 | Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*. | 2011 Aug | 1 |
154 | 21442682 | Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study. | 2011 Apr | 1 |
155 | 21453253 | Adiponectin as a regulator of vascular redox state: therapeutic implications. | 2011 May | 1 |
156 | 21477042 | Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes. | 2011 Sep | 2 |
157 | 21550959 | Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy. | 2011 Jul-Aug | 1 |
158 | 21872103 | Comment: "Quantitative insulin and C peptide levels among ED patients with sulfonylurea-induced hypoglycemia". | 2011 Sep | 1 |
159 | 21901702 | Interventions for latent autoimmune diabetes (LADA) in adults. | 2011 Sep 7 | 12 |
160 | 21959939 | [Pharmacogenetics of insulin secretagogue antidiabetics]. | 2011 Oct 9 | 2 |
161 | 22069291 | Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes. | 2011 Nov | 1 |
162 | 24843477 | Genetics and pathophysiology of neonatal diabetes mellitus. | 2011 Jun 5 | 1 |
163 | 19656320 | Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation. | 2010 Jun | 1 |
164 | 20177722 | Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus. | 2010 Sep | 1 |
165 | 20205108 | Does cellular glucose transport respond to a controlled diet and sulfonylurea therapy in type 2 diabetes mellitus? | 2010 Jan-Feb | 1 |
166 | 20222815 | Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms. | 2010 Mar | 1 |
167 | 20350924 | Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus. | 2010 Jul-Aug | 1 |
168 | 20361306 | Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide. | 2010 Mar | 1 |
169 | 20425680 | [Diabetes, insulin, insulin analogues, and cancer]. | 2010 May | 3 |
170 | 20540435 | [Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2]. | 2010 Mar-Apr | 1 |
171 | 20804735 | Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. | 2010 Sep 24 | 1 |
172 | 20887914 | Quantitative insulin and C-peptide levels among ED patients with sulfonylurea-induced hypoglycemia-a prospective case series. | 2010 Oct | 7 |
173 | 21426008 | Antidiabetic sulfonylureas modulate farnesoid X receptor activation and target gene transcription. | 2010 Apr | 1 |
174 | 22166651 | Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone. | 2010 Dec | 1 |
175 | 23226049 | The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes. | 2010 | 2 |
176 | 24843406 | Sulfonylurea action re-revisited. | 2010 Apr 22 | 3 |
177 | 18548275 | Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy. | 2009 Mar | 1 |
178 | 18768334 | Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents. | 2009 Nov-Dec | 1 |
179 | 19021632 | Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype. | 2009 Sep | 2 |
180 | 19050053 | KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. | 2009 Feb | 2 |
181 | 19065048 | Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes. | 2009 Jan | 1 |
182 | 19175375 | Insulin therapy in type 2 diabetes: what is the evidence? | 2009 May | 2 |
183 | 19275673 | The endocannabinoid system: a promising target for the management of type 2 diabetes. | 2009 Feb | 1 |
184 | 19298459 | Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes. | 2009 Apr | 1 |
185 | 19342262 | Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes. | 2009 Jun | 1 |
186 | 19421967 | Balancing risk and benefit with oral hypoglycemic drugs. | 2009 Jun | 1 |
187 | 19692134 | Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride. | 2009 Oct | 1 |
188 | 19774848 | Improved diabetic control during oral sulfonylurea treatment in two children with permanent neonatal diabetes mellitus. | 2009 Jul | 1 |
189 | 19885647 | Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies. | 2009 Nov-Dec | 1 |
190 | 19950754 | [Role of standard test meal in initiation of insulin therapy in type 2 diabetes]. | 2009 Sep-Oct | 2 |
191 | 23105828 | Effects of insulin, glimepiride and combination therapy of insulin and metformin on blood sugar and lipid profile of NIDDM patients. | 2009 Apr | 3 |
192 | 18025408 | Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. | 2008 Feb | 1 |
193 | 18156614 | The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. | 2008 Jan | 1 |
194 | 18191448 | Impact of mitochondrial calcium on the coupling of metabolism to insulin secretion in the pancreatic beta-cell. | 2008 Jul | 1 |
195 | 18215172 | Hypoglycaemia in Type 2 diabetes. | 2008 Mar | 1 |
196 | 18227474 | Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted? | 2008 Feb | 1 |
197 | 18246324 | Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin. | 2008 Apr | 1 |
198 | 18378631 | Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. | 2008 Apr 2 | 1 |
199 | 18397831 | IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. | 2008 Jun | 2 |
200 | 18397986 | Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. | 2008 Jun | 2 |